FDA zaleca wstrzymanie stosowania szczepionki Janssen

EN_01473113_0012

30,00 EUR Private use
Making print for private purpose, storage in computer memory, no distribution rights.
40,00 EUR Internet - private use
Strictly for editorial, single use on a personal (nonprofit) web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
75,00 EUR Internet commercial use
Strictly for editorial, single use on a commercial web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
90,00 EUR Print use
Strictly for editorial, single use, inside of newspaper, magazine, book (including digital version), one edition, one single country. Not for resale.

Gross prices

caption

31-03-2020 Exterior of Janssen Biologics B.V. initiate. Janssen Biologics B.V. makes, acquires and markets unique biopharmaceutical drugs. To prevent a potential pandemic, Johnson & Johnson initiated a project to develop a preventive coronavirus vaccine, Covid19, to potentially protect people from the disease. In doing so, they build on their leadership position in the development of monoclonal antibodies. Antibodies are substances that the body produces in response to bacteria, viruses or other foreign substances. Janssen Biologics' innovative products focus on three main disease categories: cardiovascular and immunological disorders and cancer. ' PPE //PICTUREPRESSEUROPE_16380002/2104131649

headline FDA zaleca wstrzymanie stosowania szczepionki Janssen

created date 2020-03-31

credit PPE/SIPA/SIPA/East News

source SIPA

byline PPE/SIPA

original transmission reference SIPA.01014184000002

weight 2,86MB

size 38cm x 28cm by 300dpi

keywords - Show

A, ACQUIRES, AND, ANTIBODIES, ARE, BACTERIA, BIOLOGICS, BIOPHARMACEUTICAL, BODY, BUILD, CANCER, CARDIOVASCULAR, CATEGORIES, CORONAVIRUS, COVID19, DEVELOP, DEVELOPMENT, DISEASE, DISORDERS, DOING, DRUGS, EXTERIOR, FOCUS, FOREIGN, FROM, IMMUNOLOGICAL, IN, INITIATE, INITIATED, INNOVATIVE, JANSSEN, JOHNSON, LEADERSHIP, MAIN, MAKES, MARKETS, MONOCLONAL, OF, ON, OR, OTHER, PANDEMIC, PEOPLE, PICTUREPRESSEUROPE, POSITION, POTENTIAL, POTENTIALLY, PPE, PREVENT, PREVENTIVE, PRODUCES, PRODUCTS, PROJECT, PROTECT, RESPONSE, SO, SUBSTANCES, THAT, THE, THEIR, THEY, THREE, TO, UNIQUE, V, VACCINE, VIRUSES,